Key facts
- Redox’s last known valuation is $310.0M (Feb 2021).
- It has raised $95.2M; the latest was Later Stage VC ($20K) in May 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, MedTech Innovator, Flybridge (New York), Texas Medical Center — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Redox
- ·The full record, as it builds
Funding rounds
No funding rounds for Redox are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Redox
Developer of a composable healthcare program interface technology designed to eradicate technical barriers in healthcare systems. The company offers a platform that standardizes data and maintains integrations to remove distractions to help focus on what's important, enabling vendors and providers to secure and share reliable healthcare data.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2014
- Employees
- 224
- Website
- redoxengine.com/
- Ownership
- Privately Held (backing)
Redox doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Redox shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Redox in its N-PORT filings yet. We sweep new filings monthly.